Gameto is revolutionizing in vitro fertilization (IVF) by introducing Fertilo, a method that matures eggs outside the body with ovarian support cells. This new approach reduces the reliance on hormone injections by 80% and shortens treatment cycles to a few days. Early studies indicate higher success rates, with 70% maturation rates and a 44% pregnancy rate—significantly better than traditional methods. Gameto's innovation holds promise for making IVF more accessible and less invasive for patients, potentially transforming the reproductive health landscape in the future.
Gameto's innovative approach to in vitro fertilization using its Fertilo technique shows a significant increase in egg maturation and pregnancy rates compared to traditional methods.
The preclinical trials of Fertilo showcased a 70% maturation rate for eggs, which significantly improved the potential for successful pregnancies when compared to standard in vitro maturation techniques.
Fertilo resulted in a 44% pregnancy rate among patients after treatment, a striking contrast to the 20% rate observed in traditional in vitro maturation cases.
Gameto's strategy aims to alleviate the burdens of current IVF procedures by drastically reducing the hormone injections and duration of treatment cycles.
Collection
[
|
...
]